How should the CT findings of periventricular and subcortical gliosis, cerebral atrophy, and ventriculomegaly be interpreted in an 88-year-old patient after a fall?

CT Interpretation in an 88-Year-Old Patient After a Fall

These CT findings indicate chronic small vessel cerebrovascular disease with significant brain atrophy, which substantially increases fall risk, cognitive impairment risk, and mortality in this elderly patient—this is not simply "normal aging" and requires comprehensive vascular risk factor management and fall prevention strategies.

What the CT Shows

The CT demonstrates three key pathological findings:

Periventricular and Subcortical Gliosis

• Represents chronic small vessel disease (cerebral small vessel disease, CSVD) with white matter damage from chronic ischemia 1
• This is vascular pathology, not benign age-related change, particularly when described as "significant" 2
• Associated with lacunar infarcts and white matter hyperintensities that would be better visualized on MRI 1

Cerebral Atrophy with Ventriculomegaly

• Indicates actual brain tissue loss, not normal aging 2
• The combination of atrophy and ventricular enlargement suggests both cortical and subcortical volume loss 3, 4
• In the context of a fall, this represents increased vulnerability to intracranial injury and poor cognitive reserve 2

Clinical Significance in This Fall Patient

Immediate Concerns

• No acute traumatic injury is mentioned (no hemorrhage, fracture, or acute infarct described), which is reassuring for immediate neurosurgical needs 5, 6
• However, the chronic changes indicate:
  • High risk for occult injuries not visible on CT 7
  • Increased fall risk (these findings are both cause and consequence of falls) 7
  • Likely underlying cognitive impairment even if not previously diagnosed 1

Why This Patient Fell

The CT findings suggest multiple contributing factors:

• Vascular cognitive impairment from the small vessel disease 1
• Gait and balance impairment from subcortical white matter disease 1
• Possible orthostatic hypotension from autonomic dysfunction
• The atrophy indicates diminished cognitive reserve affecting judgment and motor planning 2

What Should Happen Next

Acute Management

1. Complete fall evaluation beyond just imaging 7:

   • Orthostatic vital signs
   • Medication review (especially antihypertensives, sedatives, anticholinergics)
   • Cardiac evaluation if syncope suspected
   • Assess for occult injuries (hip, spine, subdural) despite negative initial CT

2. Consider MRI if 1, 2:

   • Persistent unexplained neurological symptoms
   • Need to better characterize extent of small vessel disease
   • Concern for acute stroke (CT misses small infarcts)

Longer-Term Implications

1. Vascular risk factor management is critical 1:

   • Blood pressure control (target <130/80 if tolerated)
   • Diabetes management (HbA1c <7%)
   • Lipid management
   • Antiplatelet therapy if indicated
   • Smoking cessation

2. Cognitive assessment needed 1, 2:

   • Formal cognitive testing to establish baseline
   • Screen for vascular cognitive impairment
   • The white matter disease and atrophy predict progressive cognitive decline without intervention

3. Fall prevention 7:

   • Physical therapy evaluation
   • Home safety assessment
   • Review and minimize fall-risk medications
   • Consider vitamin D supplementation
   • Gait and balance training

Critical Pitfalls to Avoid

Do NOT dismiss these findings as "age-appropriate changes" 2. The 2025 Alzheimer's Association guidelines explicitly state that cerebral atrophy and white matter changes should not be routinely interpreted as "age-related" in patients with symptoms (and falls are a symptom) 2. The extent described as "significant" indicates pathology requiring intervention.

Do NOT assume CT ruled out all acute pathology 8, 6. CT has limited sensitivity for:

• Small acute infarcts
• Early subdural hematomas in patients with atrophy (more space for blood to accumulate before symptoms)
• Subtle contusions

Do NOT focus only on the fall 1. These findings indicate systemic vascular disease requiring comprehensive management to prevent stroke, further cognitive decline, and future falls.

Prognosis

The combination of significant white matter disease and cerebral atrophy predicts 1, 3:

• High risk of recurrent falls
• Progressive cognitive decline without vascular risk factor control
• Increased stroke risk
• Increased mortality

However, aggressive vascular risk factor management can slow or prevent progression 1. The SPRINT MIND trial showed that intensive blood pressure control reduces cognitive impairment risk in this population.